A comprehensive examination of genetic alterations in TET using next-generation sequencing revealed mutations in TP53, TET2, CYLD, BRD7, SETD2, and CDKN2A in TC and GTF2I in thymomas [12,13,14,15]. This evidence concerns the gene TP53 and thymoma.